Overview
Covidien was a medical device company acquired by Medtronic in 2015 for $49.9B. Products included surgical instruments, vascular devices, and respiratory care. Now integrated into Medtronic's portfolio.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
Valuation of record
DEPLOY VERIFIEDAcquisitionAcquired by Medtronic
Key facts
HQ
Focus
Stage
Technology
Status
Products
Data & sources
Web sources
1
1 source backing this record.View all →
Covidien on the deployment map
View the global mapCovidien has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for Covidien on the DEPLOY record yet. Track Covidien to know the moment the first one is verified.
Safety record
No incidents on record for Covidien.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
Covidien in third-party press
Financial state
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- acquired
- Counterparty risk class
- moderate
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Acquisitions (1)
- acquired by Medtronicfull acquisition2014-06-15
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 25, 2026
Added to the verified registry
Sources (1)
Common questions
What is Covidien?
What does Covidien make?
Is Covidien publicly traded?
How can I invest in Covidien?
Where is Covidien headquartered?
Who owns Covidien?
Is Covidien a top robotics company?
Is Covidien safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-05
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-05
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Covidien.In the press
Recent coverage mentioning Covidien from third-party publications. Automatically surfaced; not part of the verified registry record.
Medtronic positions Hugo as ‘another choice’ for surgeons - Medical Design & Outsourcing
<a…
Medtronic Jerusalem unit to lay off 60 - Globes - Israel Business News
<a…
Medtronic to lay off 60 employees at Jerusalem R&D center - calcalistech.com
<a…
A breakup or the cusp of greatness? What Medtronic’s big changes mean for its future. - Star Tribune
<a…
North Haven targets adding shops and restaurants as Medtronics possibly expands - New Haven Register
<a…
Robotic Hernia Repair Surgery Linked To Higher Rates of Hernia Recurrence: Study - AboutLawsuits.com
<a…
Another Medtronic EVP is leaving the world’s largest device company - MassDevice
<a…
Covidien to Acquire Somanetics Corp. - Medical Device and Diagnostic industry
<a…
Medtronic Buys Covidien For $42.9B Underscoring Importance of Scale i - Medical Device and Diagnostic industry
<a…
Titan Medical names Cary G. Vance as new president, CEO - MassDevice
<a…
The road to a robot: Medtronic’s development process for its Hugo RAS system - MassDevice
<a…
Manufacturing Error Leads To Class I Recall For Covidien Ventilator - insights.citeline.com
<a…
Machine-readable surfaces
- Markdown mirror: /companies/covidien.md
- RSS feed: /companies/covidien/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/524f82a9-f06c-4e86-855a-610bab61ecda
- Revision history: /companies/covidien/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Reality vs attention
Not enough verified signal yet to place Covidien against peers. Reality and attention percentiles publish once the underlying record clears its data floor.
6-month trend
Analysis
Limited public funding data for capital position assessment.
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 18, 2026